Wakely conducts national HHS-RADV IVA surveys to assist participants in estimating their RADV-adjusted risk transfers months before CMS releases official results. Obtaining timely estimates of RADV impacts and detailed deliverables allow issuers to understand RADV impact to risk transfers and manage financial risks.

Read this white paper to learn more about 2019 RADV study results, key insights, and trends from previous years.
Read More Here